89bio vs Madrigal Pharmaceuticals
89bio
Developing and commercializing innovative therapies for the treatment of liver and cardio-metabolic diseases
123 employees · est. 2018 · San Francisco, United States
Madrigal Pharmaceuticals
Madrigal is focused on delivering novel therapeutics for MASH, a serious liver disease
1129 employees · est. 2016 · Conshohocken, United States
Madrigal Pharmaceuticals is the older company (2018 vs 2016); Madrigal Pharmaceuticals is the larger of the two.
Side-by-Side Comparison
| Metric | 89bio | Madrigal Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2016 older |
| Headquarters | ||
| Headquarters | San Francisco, United States | Conshohocken, United States |
| Employees | ||
| Employees | 123 | 1129 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Pharmaceutical | Biopharma, Biotechnology, Medical Devices |
| Funding Stage | ||
| Funding Stage | Post-IPO Equity | IPO |
| Total Funding | ||
| Total Funding | $773.20M | $1.68B |
| Funding Rounds | ||
| Funding Rounds | 7 | 9 |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical CompanyClinical-stageFGF21 AnalogNASH TreatmentSHTG TreatmentLiver Diseases +9 | BiopharmaceuticalTherapeuticsMetabolic DiseasesLiver DiseaseNASH TreatmentCardiovascular-metabolic Diseases +9 |
| Website | ||
| Website | 89bio.com | madrigalpharma.com |
About 89bio
89bio 89bio is a clinical-stage biopharmaceutical company with a focus on developing and commercializing innovative therapies for the treatment of liver and cardio-metabolic diseases. Their lead product candidate, BIO89-100, is an engineered glycoPEGylated analog of FGF21 designed for the treatment...
About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals is a biopharmaceutical company founded in 2016, focusing on developing therapeutics for metabolic and fatty liver diseases. The company's first therapy received accelerated approval from the U.S. Food and Drug Administration (FDA) for the treatment of adults with nonalcoholi...
Also comparing in this category
Comparing more than these two?
Get 89bio, Madrigal Pharmaceuticals and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does 89bio compare?
A PDF of 89bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare 89bio with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at 89bio on 9 Jun 2026, and Madrigal Pharmaceuticals on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
